HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by SILVERBERG, S. G. Articles by MAKOWSKI, E. L. Search for Related Content PubMed PubMed Citation Articles by SILVERBERG, S. G. Articles by MAKOWSKI, E. L.

Endometrial Carcinoma in Young Women Taking Oral Contraceptive Agents

From the Departments of Pathology and Obstetrics and Gynecology, University of Colorado School of Medicine, Denver, Colorado

Abstract

The first 21 cases recorded in the Registry for Endometrial Carcinoma in Young Women Taking Oral Contraceptive Agents are reported. We have found no other such cases in the literature, and indeed several authors have stated that these agents, because of their predominantly progestational action, would be expected to be protective against this disease. In 8 of the 21 patients, factors were present which militated against a close relation between oral contraceptives and carcinoma, and 5 of these S patients had taken only or predominantly combined agents. On the other hand, 11 of the remaining 13 patients took sequential agents, a ratio directly opposite that of the usage of combined and sequential agents in the American population. The possible reasons for the excess of sequential agents, chiefly Oracon, arc discussed, and directions for future study are suggested.

This article has been cited by other articles:

				G. E. Hale, C. L. Hughes, and J. M. Cline Endometrial Cancer: Hormonal Factors, the Perimenopausal ""Window of Risk,"" and Isoflavones J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 3 - 15. [Abstract] [Full Text] [PDF]

				E. T. Matloff, H. Shappell, K. Brierley, B. A. Bernhardt, W. McKinnon, and B. N. Peshkin What Would You Do? Specialists' Perspectives on Cancer Genetic Testing, Prophylactic Surgery, and Insurance Discrimination J. Clin. Oncol., June 12, 2000; 18(12): 2484 - 2492. [Abstract] [Full Text] [PDF]

				B. Henderson, R. Ross, and M. Pike Hormonal chemoprevention of cancer in women Science, January 29, 1993; 259(5095): 633 - 638. [Abstract] [PDF]